What a longevity peptide program should measure: labs, goals, retests
A good longevity peptide program measures before it prescribes. It starts with a baseline blood panel (IGF-1, A1c, fasting insulin, lipids or ApoB, hs-CRP, a metabolic panel, a blood count, sex hormones and thyroid) plus functional baselines such as body composition and grip strength, sets one or two measurable goals per protocol, retests at roughly 8 to 12 weeks and then on a schedule, and defines in advance when to stop. A clinic that sells peptides without that structure is selling products, not running a program.
That distinction matters because the science is still young. As Cedars-Sinai explains, peptides show real potential in aging research, but much of the evidence is early. The FDA has not approved BPC-157, TB-500 or most other peptides marketed for longevity for those uses, and many reach patients through compounding. When the evidence is thin, your own data becomes the safety net. Longevity is not accidental, it is intentional, and intention starts with a baseline.
1. Start with a baseline blood panel
Before the first injection, you need a snapshot of where your body is today. Without it, there is no way to tell whether a peptide helped, did nothing, or pushed a marker the wrong way. The core panel below is a sensible starting point; your physician should tailor it to the specific protocol and your history.
| Marker | What it tells you | Why it matters on peptides |
|---|---|---|
| IGF-1 | A downstream signal of growth hormone activity | Growth hormone peptides such as sermorelin and ipamorelin aim to raise growth hormone; IGF-1 shows whether they did, and whether they went too far |
| A1c and fasting insulin | Long-term blood sugar and insulin sensitivity | Growth hormone tends to raise blood sugar, so these need a starting point |
| Lipid panel or ApoB | Cardiovascular risk | Longevity is mostly about heart and metabolic health; you want to see these hold steady or improve |
| hs-CRP | Low-grade inflammation | Useful context for recovery and anti-inflammatory protocols |
| CMP (comprehensive metabolic panel) | Kidney and liver function, electrolytes, glucose | Confirms the organs that process medications are working well |
| CBC (complete blood count) | Red cells, white cells, platelets | Screens for anemia, infection and other issues that change the plan |
| Sex hormones | Testosterone, estradiol and related markers | Low energy, slow recovery and body composition changes are often hormonal, not a peptide problem |
| Thyroid | TSH and related markers | Thyroid issues can mimic the fatigue and weight changes people hope peptides will fix |
If a clinic skips this step, read our breakdown of the risks of peptide therapy without bloodwork. At BioCure Health, peptide therapy starts with an evaluation and labs, and our comprehensive Male and Female panels cover hormones, thyroid, lipids, metabolic and organ markers. Every result is interpreted with a specialist. You can see the full range on our diagnostics page.
2. Add functional baselines
Blood work shows chemistry. Functional tests show how your body actually performs, which is usually what you care about. A few simple measures, taken the same way each time, turn vague impressions into trends you can track.
- Body composition. A DEXA scan or a quality bioimpedance scale separates lean mass from fat. Scale weight alone can hide a loss of muscle, which is the opposite of what a longevity plan wants.
- Grip strength. A handheld dynamometer takes a minute and gives a repeatable number. Grip strength is widely used in aging research as a marker of overall strength and function.
- Sleep. A wearable or a standard sleep questionnaire gives you a baseline for duration and quality. Many growth hormone protocols are started with better sleep as a goal, so you need to know where you began.
- VO2 max estimate. Cardiorespiratory fitness is one of the strongest signals of long-term health. Most wearables and simple field tests offer an estimate.
Be honest about precision. Wearable sleep scores and VO2 max estimates are approximations. What makes them useful is consistency: same device, same conditions, same time of day. A trend from an imperfect tool beats a single perfect number you never repeat.
3. Set one or two measurable goals per protocol
A program without goals cannot fail, which also means it cannot succeed. Each protocol should come with one or two specific targets you and your physician agree on before you start. More than that, and you cannot tell which change came from the peptide.
| Protocol | Example goal | How it is measured |
|---|---|---|
| BPC-157 + TB-500 recovery stack | Return to a specific training load with less pain | Pain score and training log at baseline and retest |
| Sermorelin or ipamorelin | Better sleep and improved body composition, with IGF-1 kept in range | Sleep data, body composition scan, IGF-1 |
| GLP-1 within a weight program | Fat loss while preserving lean mass | Body composition scan, A1c, fasting insulin, lipids |
| GHK-Cu + BPC-157 + TB-500 "Glow" stack | Visible skin and recovery goals you define up front | Standardized photos and symptom notes |
These are examples, not promises. For several of these peptides, particularly BPC-157 and TB-500, most of the supporting research comes from animal and laboratory studies, not large human trials. That is exactly why a measurable goal matters: it tells you whether the protocol is earning its place in your routine.
4. Retest at 8 to 12 weeks, then on a schedule
The first retest answers two questions: is the protocol safe for you, and is it working? Most longevity programs aim that first checkpoint at around two to three months, long enough for markers and function to move, short enough to catch problems early. BioCure says its longevity-focused protocols typically show measurable results over 8 to 12 weeks, with follow-up labs.
| Checkpoint | What gets measured | What you decide |
|---|---|---|
| Baseline | Full blood panel, functional tests, goals written down | Whether a peptide makes sense at all, and which one |
| Early check-in | Side effects, injection technique, symptoms | Whether to continue as planned |
| 8 to 12 weeks | Repeat relevant labs (IGF-1 for growth hormone peptides, A1c and insulin, lipids, CMP) and functional tests | Continue, adjust the dose, change the protocol, or stop |
| Ongoing | Periodic labs and functional retests at intervals your physician sets, and whenever the protocol changes | Whether the benefit is holding and markers stay in range |
A decade ago, most people only did blood work when something felt wrong. A well-run program flips that: labs are scheduled, not reactive.
5. Know the stop rules before you start
The most overlooked part of a peptide program is the exit. Good programs define stop rules on day one, so the decision is not made under pressure later.
| Trigger | Examples | Typical response |
|---|---|---|
| Side effects | Persistent injection site reactions, swelling or fluid retention, numbness or tingling, ongoing headaches, signs of an allergic reaction | Pause and review with your physician; stop if they persist |
| Lab changes | IGF-1 above the age-adjusted reference range, rising A1c or fasting insulin, new liver or kidney changes | Lower the dose or stop, then retest |
| No benefit | Your agreed goal has not moved by the retest | Stop or switch, rather than adding more peptides |
IGF-1 deserves special attention. In conventional endocrinology, growth hormone treatment is monitored with IGF-1 and kept within the age-appropriate reference range. A longevity program using growth hormone peptides should hold itself to at least that standard. Any new or worrying symptom, especially chest pain, trouble breathing or swelling of the face or throat, needs prompt evaluation by a clinician rather than waiting for the next scheduled check.
6. Optional: epigenetic age testing, and its limits
Epigenetic tests such as TrueAge estimate biological age from DNA methylation patterns, chemical tags on your DNA that shift with age. BioCure offers the TrueAge Epigenetic Exam for $625 on our diagnostics page.
What it can show: an estimate of how your biological age compares with your calendar age, and a reference point you can compare against later.
What it cannot show: it does not diagnose disease, it cannot prove that a specific peptide worked, and short-term changes in an epigenetic clock can reflect measurement noise as much as real change. There is not yet strong evidence that moving an epigenetic score translates into longer or healthier life.
The best use is as a long-horizon add-on: a baseline, then a repeat after a meaningful stretch of time, read alongside your standard labs and functional tests, never in place of them.
7. How to use this checklist when comparing peptide clinics
Whether you are searching for peptide therapy longevity clinics in New York City, Florida or anywhere else in the United States, the same questions separate a medical program from a storefront:
- Does a physician review labs before anything is prescribed?
- Who interprets your results, and will you get a 1:1 review?
- Is there a scheduled retest, and what will it measure?
- Are the stop rules written down?
- Where do the peptides come from? Look for prescriptions filled by licensed compounding pharmacy partners, not research chemicals.
- How does pricing work: membership, bundled or a la carte, and are labs, consults and follow-up included?
Where BioCure fits: we are a physician-led telehealth longevity clinic based in the Fort Lauderdale area, licensed to treat patients in 47 states, with in-person or video appointments. Peptide therapy starts with a $199 physician video consultation (creditable toward a membership), then labs through an at-home kit or in-lab testing, with results in 7 to 14 days. We offer 15+ protocols, and ongoing follow-up is included. We do not bill insurance directly, though many patients use HSA or FSA funds with the documentation we provide. If you want peptides with no labs and no follow-up, we are not the right fit. If you want a measured, monitored program, we are built for that.
Frequently asked questions
What blood tests should I get before starting peptide therapy?
A solid baseline usually includes IGF-1, A1c, fasting insulin, a lipid panel or ApoB, hs-CRP, a comprehensive metabolic panel, a complete blood count, sex hormones and thyroid markers. Your physician should tailor the panel to the protocol, for example always checking IGF-1 before a growth hormone peptide. Without a baseline, there is no way to judge safety or results.
How long does it take to see results from longevity peptides?
BioCure says its longevity-focused protocols typically show measurable results over 8 to 12 weeks, which is also when the first follow-up labs are usually done. Results vary by person and protocol, and some peptides have limited human evidence, so no outcome is guaranteed. The retest is where you find out whether it is working for you.
Why does IGF-1 matter on peptides like sermorelin or ipamorelin?
These peptides aim to increase growth hormone, and IGF-1 is the main blood marker of growth hormone activity. It shows whether the peptide is having an effect and whether levels have climbed above the age-appropriate range. An IGF-1 above range is a common reason to lower the dose or stop.
Are peptides for longevity FDA approved?
Most peptides marketed for longevity, including BPC-157 and TB-500, are not FDA-approved for that use, and much of their evidence comes from animal or lab studies. That is why medical supervision, lab monitoring and a reputable licensed compounding pharmacy matter. Cedars-Sinai describes the field as promising but early.
Is a TrueAge epigenetic test worth it?
It can be a useful long-term reference point if you are curious about biological age, and at BioCure it costs $625. It does not diagnose disease or prove a peptide worked, and short-term changes can be noise. Treat it as an add-on to standard labs, not a replacement.
When should I stop a peptide protocol?
Stop or pause when side effects persist, when labs move the wrong way (such as IGF-1 above range or rising blood sugar markers), or when your agreed goal has not improved by the retest. A good program writes these rules down before you start. Adding more peptides is rarely the right answer to no benefit.
The difference between a longevity program and a peptide purchase is not the vial. It is the baseline, the goal, the retest and the exit plan. Are you living by default or by design?
Let BioCure Health lead you in the right direction. Call or text us to schedule an introductory call at 754-206-0838. Your future self will thank you.